Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Pseudomonas aeruginosa

Organism: Pseudomonas aeruginosa
cellular organisms; Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas; Pseudomonas aeruginosa group

Attributes

Submission: Centers for Disease Control and Prevention, Brian Yoo; 2019-06-04

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Testing standard
amikacin	susceptible	==	8	mg/L	MIC	CLSI
ampicillin	not defined	>	32	mg/L	MIC	CLSI
ampicillin-sulbactam	not defined	>	32/16	mg/L	MIC	CLSI
aztreonam	resistant	==	32	mg/L	MIC	CLSI
cefazolin	not defined	>	8	mg/L	MIC	CLSI
cefepime	intermediate	==	16	mg/L	MIC	CLSI
cefotaxime	not defined	>	64	mg/L	MIC	CLSI
cefoxitin	not defined	>	16	mg/L	MIC	CLSI
ceftazidime	susceptible	==	8	mg/L	MIC	CLSI
ceftazidime-avibactam	susceptible	==	8/4	mg/L	MIC	CLSI
ceftolozane-tazobactam	susceptible	==	1/4	mg/L	MIC	CLSI
ceftriaxone	not defined	>	32	mg/L	MIC	CLSI
ciprofloxacin	intermediate	==	2	mg/L	MIC	CLSI
colistin	susceptible	==	1	mg/L	MIC	CLSI
delafloxacin	resistant	==	4	mg/L	MIC	CLSI
doripenem	susceptible	==	0.5	mg/L	MIC	CLSI
ertapenem	not defined	>	8	mg/L	MIC	CLSI
gentamicin	susceptible	==	2	mg/L	MIC	CLSI
imipenem	susceptible	==	2	mg/L	MIC	CLSI
levofloxacin	resistant	>	8	mg/L	MIC	CLSI
meropenem	susceptible	==	2	mg/L	MIC	CLSI
minocycline	not defined	>	16	mg/L	MIC	CLSI
piperacillin-tazobactam	intermediate	==	32/4	mg/L	MIC	CLSI
tetracycline	not defined	>	32	mg/L	MIC	CLSI
tigecycline	not defined	>	4	mg/L	MIC	CLSI
tobramycin	susceptible	==	1	mg/L	MIC	CLSI
trimethoprim-sulfamethoxazole	not defined	>	8/152	mg/L	MIC	CLSI